The California Health Care Foundation's CHCF Innovation Fund announced this week that it has invested a total of slightly more than $1 million in Madison, Wisconsin-based Asthmapolis, which offers a FDA-cleared inhaler sensor and app for people with asthma, COPD, or cystic fibrosis. CHCF has made two investments in Asthmapolis over the years but the bulk of the $1 million makes up its most recent...
iSonea showed off its wares at HIMSS in the Qualcomm Life booth. The Asthma Sense iPhone app pictured is not yet available in the AppStore.
iSonea, makers of the WheezoMeter, has begun recruiting for a post-market study of its asthma monitoring device for children under the age of 12 years old. The company aims to determine the device's ability to accurately assess wheeze rate in a group of...
